Signal Transduction And Targeted Therapy

Signal Transduction And Targeted Therapy

信号转导与靶向治疗

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Signal Transduction And Targeted Therapy》是由Springer Nature出版社于2016年创办的英文国际期刊(ISSN: 2095-9907,E-ISSN: 2059-3635),该期刊长期致力于生化与分子生物学领域的创新研究,主要研究方向为Biochemistry, Genetics and Molecular Biology-Genetics。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比1%),以发表生化与分子生物学领域等方向的原创性研究为核心(研究类文章占比76.04%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在313篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Signal Transduction And Targeted Therapy审稿周期约为5 Weeks。该刊近年未被列入国际预警名单,年发文量约313篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 313 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学
1区 1区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学
1区 1区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学
1区 1区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学
1区 1区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学
1区 1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 1 / 328

99.8

学科:CELL BIOLOGY SCIE Q1 2 / 207

99.3

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 3 / 328

99.24

学科:CELL BIOLOGY SCIE Q1 5 / 207

97.83

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 3 / 313

99.2

学科:CELL BIOLOGY SCIE Q1 5 / 205

97.8

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 5 / 313

98.56

学科:CELL BIOLOGY SCIE Q1 6 / 205

97.32

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:81.6 SJR:17.74 SNIP:11.887
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Genetics Q1 1 / 357

99%

大类:Biochemistry, Genetics and Molecular Biology 小类:Cancer Research Q1 2 / 233

99%

期刊发文

  • Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 stud

    Author: Gui, Lin; Liu, Haifeng; Wang, Huaqing; Cao, Junning; Li, Yufu; Yu, Yong; Gao, Yuhuan; Li, Zhenling; Shen, Jianzhen; Zhang, Lei; Zhang, Qingyuan; Pan, Hongming; Zheng, Meifang; Ke, Xiaoyan; He, Hesheng; Guo, Shuangshuang; Wang, Yihao; Xu, Xiaohong; Zou, Liqun; Wu, Wentao; Shi, Yuankai

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02646-z

  • Tumor-derived DNA drives cancer-associated anemia by promoting reticulocyte clearanc

    Author: Yuan, Ting; Liu, Xuebing; Wu, Yucui; Li, Shanshan; Chu, Han; Li, Qing; Chen, Zefang; Liu, Haichuan; Mao, Tao; Zha, Haoran; Cheng, Xiaoming; Jing, Jing; Li, Chengmu; Peng, Lina; Chen, Xiaoxing; Liao, Qian; Yu, Renren; Lv, Hao; Zhang, Junwei; Wang, Zhongyu; Jia, Qingzhu; Long, Haixia; Chen, Degao; Zhu, Bo

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02674-9

  • Endothelial GABA protects against aortic dissection by inhibiting endothelial and mitochondrial dysfunction and maintaining vascular homeostasi

    Author: Shao, Lianbo; Yu, You; Huang, Haoyue; Chen, Yihuan; Teng, Xiaomei; Shen, Han; Ding, Yinglong; Zhou, Yihong; Wang, Tingyu; Shen, Zhenya

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02619-2

  • Robust neurogenesis in chronic stroke monkeys following mesenchymal stem cell transplantation plus intermittent theta-burst stimulatio

    Author: Ma, Yuan-Huan; Chen, Geng-Bin; Wu, Man-Feng; Li, Ge; Zhang, Yu; Lv, Jian-Ping; Wen, Min; Cai, Lei; Zhang, Cai-Ling; Jiang, Jun-Bo; Zhang, Ke; Zhang, Ke-Jun; Liu, Ying; Liu, Zhou; Chen, Jia-Lin; Lin, Tuo; Wang, Li-Xin; Xu, Guang-Qing; Zeng, Xiang; Lan, Yue

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02694-5

  • Temporal assessment of behavior in Parkinson's visual hallucinations via a multidimensional analysis strateg

    Author: Zhang, Quan-Xin; Zhang, Yi-Xuan; Jiang, Chen-Chen; Cheng, Jia-Wen; Tao, Shen-Jia; Pan, Yun-Long; Kohji, Fukunaga; Chen, Shu-Yang; Mao, Xing-Feng; Zhang, Li; Lu, Ying-Mei; Han, Feng

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02651-2

  • Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumoni

    Author: Yuan, Lunzhi; Xiao, Haiqing; Liu, Xuan; Zhou, Ming; Zhang, Chang; Wu, Kun; Ye, Jianghui; Zhang, Longmei; Li, Xinglin; Ma, Jian; Fang, Mujin; Zhang, Yali; Yuan, Quan; Chen, Rirong; Zhu, Huachen; Guan, Yi; Cheng, Tong; Xia, Ningshao

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02636-1

  • Targeting ATP11B-YAP axis repairs mitochondrial function and inhibits neuronal ferroptosis to attenuate age-related cognitive declin

    Author: Qi, Wenxin; Liu, Qian; Dong, Naijun; Sun, Xiuqiao; Wu, Peiru; Zhou, Jianxin; Sun, Ruiqi; Liu, Yihao; Zhao, Robert Chunhua; Wang, Jiao

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02652-1

  • Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistanc

    Author: Yang, Zuming; Cao, Shuaishuai; Zhang, Jiaen; Nie, Xiaohua; Wang, Zhimin; Yang, Shaojun; Wang, Jingshu; Sun, Xin; Kuang, Xueli; Huang, Huiming; Wei, Zifan; Duan, Pengfei; Tang, Mingwan; Zhang, Liyu; Ren, Zhenhua; Lan, Xun; Fu, Yang-Xin; Zhang, Liguo; Zhang, Xuyuan; Liang, Yong

    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2026; Vol. 11, Issue 1, pp. -. DOI: 10.1038/s41392-026-02664-x